... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
---|---|---|---|---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Truxima | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Truxima | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum Biosimilar medicine |
Ruxience | Concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS | € 383.76 | skatīt informāciju par zālēm un iepakojumiem | |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum Biosimilar medicine |
Ruxience | Concentrate for solution for infusion | 500 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1901.58 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
Reimbursed medicines reference product |
Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) Reimbursed medicines reference product |
L01FA01 — ANTINEOPLASTIC AGENTS | € 418.50 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
Reimbursed medicines reference product |
Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 500 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) Reimbursed medicines reference product |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1039.84 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 579.13 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1444.09 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Solution for injection | 1400 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 2094.43 | skatīt informāciju par zālēm un iepakojumiem |
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum | MabThera | Solution for injection | 1600 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Blitzima | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Blitzima | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem |